Mark Jones

Mark Jones has a diverse work experience in the field of immunoglycobiology and immunology. Mark started their career at Case Western Reserve University as a Postdoctoral Scholar, where they focused on sialylation and glycobiology in conjunction with the immune system. During this time, they worked on a project investigating B cell independent sialylation of IgG molecules.

After their postdoctoral fellowship, Mark joined Beth Israel Deaconess Medical Center as an Instructor and Staff Scientist. Mark'srole at the National Center for Functional Glycomics involved facilitating immunoglycobiology projects and collaborations, with an emphasis on securing grants. Notably, they contributed to a funded project exploring glycan and glycoproteomics biomarkers related to Alzheimer's Disease.

Currently, Mark is working at Vor Biopharma as a Senior Scientist. Mark'sspecific responsibilities in this role are not provided in the information given.

Mark Jones completed their Bachelor of Science (BS) degree in Biomedical/Medical Engineering from The Johns Hopkins University, where they studied from 1999 to 2003. Mark then pursued a Masters of Engineering (MSE) degree in the same field at The Johns Hopkins University from 2003 to 2006. Mark further advanced their education by attending the University at Buffalo, where they obtained a Doctor of Philosophy (Ph.D.) in Cellular and Molecular Biology from 2006 to 2012.